Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/9568

Decabromodiphenyl Ether: Target Organs and Levels of Evidence for TR-309

Toxicology and Carcinogenesis Studies of Decabromodiphenyl Oxide (CASRN 1163-19-5) in F344/N Rats and B6C3F1 Mice (Feed Studies)

Chemical (Study Title)
CASRN		Peer Review DateRoute/Exposure LevelsStudy Laboratory
Decabromodiphenyl oxide
1163-19-5		08/14/1985Dosed-Feed
0,25000,50000 PPM/50 PER GROUP		Hazleton, Vienna

Levels of Evidence

Male Rats: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: NEOPLASTIC NODULE 1/50 7/50 15/49
Female Rats: Some Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: NEOPLASTIC NODULE 1/50 3/49 9/50
Male Mice: Equivocal Evidence
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Liver: ADENOMA 4/50 12/50 12/50 OR CARCINOMA 5/50 14/50 8/50 COMBINED 8/50 22/50 18/50
  • Thyroid Gland Follicular Cell: ADENOMA 0/50 3/50 3/50 OR CARCINOMA 0/50 1/50 0/50 COMBINED 0/50 4/50 3/50
Non-Neoplastic Lesions
  • THYROID GLAND: HYPERPLASIA, FOLLICULAR CELL
Female Mice: No Evidence